PEGylated dendrimers: a novel mechanism of drug delivery
Monash Institute of Pharmaceutical Science (MIPS) researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd (ASX:SPL) have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide. read more
"We are excited by the possibilities that this technology may provide in the improved treatment of particular types of diseases, including metastatic cancer, lymphoma, HIV and metastitial tuberculosis," Professor Porter said.
PEGylated dendrimers: a novel mechanism of drug delivery
Monash Institute of Pharmaceutical Science (MIPS) researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that ...
Thu 11 Mar 10 from PhysOrg
PEGylated dendrimers: A novel mechanism of drug delivery, Fri 12 Mar 10 from ScienceDaily
PEGylated dendrimers: a novel mechanism of drug delivery, Thu 11 Mar 10 from e! Science News
PEGylated dendrimers: a novel mechanism of drug delivery, Thu 11 Mar 10 from Science Blog
PEGylated dendrimers: a novel mechanism of drug delivery, Thu 11 Mar 10 from Eurekalert
- Pages: 1
Total number of sources: 5
Bookmark
